Literature DB >> 30987853

Trends and spatial distribution of MMR vaccine coverage in Brazil during 2007-2017.

Flávia C Pacheco1, Giovanny V A França2, Guilherme A Elidio3, Carla Magda Allan S Domingues3, Cesar de Oliveira4, Dirce B Guilhem5.   

Abstract

We analyzed the time trends and spatial distribution of MMR vaccine coverage in Brazil during 2007-2017. In early 2018, a measles outbreak started in the North region of Brazil, reaching 11 of the 27 federal units by January 24, 2019. In this period, 10,302 cases were confirmed. Although the reintroduction of measles in Brazil is likely due to migration from Venezuela, the spread of the virus was made possible by the low levels of MMR coverage, as a result of significant decreases during the study period. Areas with high concentration of municipalities with low coverage are more susceptible to the spread of the virus, especially in the North and Northeast regions. Increasing vaccination coverage is essential to block the ongoing outbreak in Brazil. Vaccination strategies might target priority areas, especially those with a marked decrease in coverage. Moreover, it is essential to extend actions to travelers, migrants and refugees.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Keywords:  Measles; Measles-mumps-rubella vaccine; Spatial analysis; Time series studies; Vaccination coverage

Year:  2019        PMID: 30987853     DOI: 10.1016/j.vaccine.2019.04.019

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Yellow fever vaccination before and during the covid-19 pandemic in Brazil.

Authors:  Tércia Moreira Ribeiro da Silva; Ana Carolina Micheletti Gomide Nogueira de Sá; Elton Junio Sady Prates; Daiana Elias Rodrigues; Thales Philipe Rodrigues da Silva; Fernanda Penido Matozinhos; Ed Wilson Rodrigues Vieira
Journal:  Rev Saude Publica       Date:  2022-06-13       Impact factor: 2.772

2.  Number of doses of Measles-Mumps-Rubella vaccine applied in Brazil before and during the COVID-19 pandemic.

Authors:  Tércia Moreira Ribeiro da Silva; Ana Carolina Micheletti Gomide Nogueira de Sá; Ed Wilson Rodrigues Vieira; Elton Junio Sady Prates; Mark Anthony Beinner; Fernanda Penido Matozinhos
Journal:  BMC Infect Dis       Date:  2021-12-09       Impact factor: 3.090

3.  Changing demographics and immunity to vaccine preventable diseases in people with HIV in Ireland.

Authors:  C Kerr; M Kelleher; S Coughlan; B Crowley; E J O'Reilly; C Bergin
Journal:  BMC Infect Dis       Date:  2022-06-29       Impact factor: 3.667

Review 4.  Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications.

Authors:  F T Cutts; E Dansereau; M J Ferrari; M Hanson; K A McCarthy; C J E Metcalf; S Takahashi; A J Tatem; N Thakkar; S Truelove; E Utazi; A Wesolowski; A K Winter
Journal:  Vaccine       Date:  2019-11-29       Impact factor: 3.641

5.  Pandemic and vaccine coverage: challenges of returning to schools.

Authors:  Ana Paula Sayuri Sato
Journal:  Rev Saude Publica       Date:  2020-11-09       Impact factor: 2.106

6.  Evolution of the quality of prenatal care in the primary network of Brazil from 2012 to 2018: What can (and should) improve?

Authors:  Elaine Tomasi; Thales Moura de Assis; Paulo Guilherme Muller; Denise Silva da Silveira; Rosália Garcia Neves; Everton Fantinel; Elaine Thumé; Luiz Augusto Facchini
Journal:  PLoS One       Date:  2022-01-18       Impact factor: 3.240

7.  Measles, rubella, mumps and Toxoplasma gondii antibodies in saliva of vaccinated students of schools and universities in São Paulo City, Brazil.

Authors:  Barbara Carvalho Fialho Sampaio; Jaqueline Polizeli Rodrigues; Luciana Regina Meireles; Heitor Franco de Andrade Junior
Journal:  Braz J Infect Dis       Date:  2019-12-19       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.